MedApp (MDA) Stock Overview
Engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
MDA Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
MedApp S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.23 |
| 52 Week High | zł0.37 |
| 52 Week Low | zł0.068 |
| Beta | 1.26 |
| 1 Month Change | 74.07% |
| 3 Month Change | 117.59% |
| 1 Year Change | 26.68% |
| 3 Year Change | -35.08% |
| 5 Year Change | -76.73% |
| Change since IPO | 161.11% |
Recent News & Updates
Recent updates
A Look At The Intrinsic Value Of MedApp S.A. (WSE:MDA)
Feb 04
Why Investors Shouldn't Be Surprised By MedApp S.A.'s (WSE:MDA) 26% Share Price Surge
Mar 26Is It Too Late To Consider Buying MedApp S.A. (WSE:MDA)?
Jan 29Can You Imagine How Jubilant MedApp's (WSE:MDA) Shareholders Feel About Its 292% Share Price Gain?
Mar 12MedApp S.A.'s (WSE:MDA) Stock Is Going Strong: Have Financials A Role To Play?
Jan 18Announcing: MedApp (WSE:MDA) Stock Soared An Exciting 363% In The Last Five Years
Nov 26
Shareholder Returns
| MDA | PL Healthcare Services | PL Market | |
|---|---|---|---|
| 7D | -12.0% | 2.9% | -4.8% |
| 1Y | 26.7% | -3.5% | 22.0% |
Return vs Industry: MDA exceeded the Polish Healthcare Services industry which returned -3.5% over the past year.
Return vs Market: MDA exceeded the Polish Market which returned 22% over the past year.
Price Volatility
| MDA volatility | |
|---|---|
| MDA Average Weekly Movement | 24.4% |
| Healthcare Services Industry Average Movement | 6.5% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in PL Market | 10.9% |
| 10% least volatile stocks in PL Market | 3.4% |
Stable Share Price: MDA's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: MDA's weekly volatility has increased from 16% to 24% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 8 | David Odrakiewicz | medapp.pl |
MedApp S.A. engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife Holo, a technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. HoloComm, an innovative solution for easy and convenient work on files in 3D.
MedApp S.A. Fundamentals Summary
| MDA fundamental statistics | |
|---|---|
| Market cap | zł58.78m |
| Earnings (TTM) | -zł93.00k |
| Revenue (TTM) | zł4.48m |
Is MDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDA income statement (TTM) | |
|---|---|
| Revenue | zł4.48m |
| Cost of Revenue | zł1.59m |
| Gross Profit | zł2.89m |
| Other Expenses | zł2.98m |
| Earnings | -zł93.00k |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00037 |
| Gross Margin | 64.43% |
| Net Profit Margin | -2.08% |
| Debt/Equity Ratio | 5.3% |
How did MDA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/08 03:46 |
| End of Day Share Price | 2026/03/06 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MedApp S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Adrian Kowollik | East Value Research GmbH |